Literature DB >> 11749378

Phosphoinositide-regulated kinases and phosphoinositide phosphatases.

N R Leslie1, R M Biondi, D R Alessi.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11749378     DOI: 10.1021/cr000091i

Source DB:  PubMed          Journal:  Chem Rev        ISSN: 0009-2665            Impact factor:   60.622


× No keyword cloud information.
  25 in total

Review 1.  Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm.

Authors:  Alexandra C Newton
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

2.  Evidence that the tandem-pleckstrin-homology-domain-containing protein TAPP1 interacts with Ptd(3,4)P2 and the multi-PDZ-domain-containing protein MUPP1 in vivo.

Authors:  Wendy A Kimber; Laura Trinkle-Mulcahy; Peter C F Cheung; Maria Deak; Louisa J Marsden; Agnieszka Kieloch; Stephen Watt; Ronald T Javier; Alex Gray; C Peter Downes; John M Lucocq; Dario R Alessi
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

Review 3.  Back to the future: oral targeted therapy for RA and other autoimmune diseases.

Authors:  John J O'Shea; Arian Laurence; Iain B McInnes
Journal:  Nat Rev Rheumatol       Date:  2013-02-19       Impact factor: 20.543

4.  TPIP: a novel phosphoinositide 3-phosphatase.

Authors:  S M Walker; C P Downes; N R Leslie
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

5.  A novel regulation of IRS1 (insulin receptor substrate-1) expression following short term insulin administration.

Authors:  Antonio J Ruiz-Alcaraz; Hui-Kang Liu; Daniel J Cuthbertson; Edward J McManus; Simeen Akhtar; Christopher Lipina; Andrew D Morris; John R Petrie; Hari S Hundal; Calum Sutherland
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

6.  Insulin regulation of hepatic insulin-like growth factor-binding protein-1 (IGFBP-1) gene expression and mammalian target of rapamycin (mTOR) signalling is impaired by the presence of hydrogen peroxide.

Authors:  Satish Patel; Jeroen Van Der Kaay; Calum Sutherland
Journal:  Biochem J       Date:  2002-07-15       Impact factor: 3.857

7.  Interaction of the protein tyrosine phosphatase PTPL1 with the PtdIns(3,4)P2-binding adaptor protein TAPP1.

Authors:  Wendy A Kimber; Maria Deak; Alan R Prescott; Dario R Alessi
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

8.  The in vivo role of PtdIns(3,4,5)P3 binding to PDK1 PH domain defined by knockin mutation.

Authors:  Edward J McManus; Barry J Collins; Peter R Ashby; Alan R Prescott; Victoria Murray-Tait; Laura J Armit; J Simon C Arthur; Dario R Alessi
Journal:  EMBO J       Date:  2004-04-29       Impact factor: 11.598

9.  In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation.

Authors:  Barry J Collins; Maria Deak; J Simon C Arthur; Laura J Armit; Dario R Alessi
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

Review 10.  PTEN function: how normal cells control it and tumour cells lose it.

Authors:  Nick R Leslie; C Peter Downes
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.